Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups.

Authors

• Omran Saifi
• Chelsea C Pinnix
• Chris R Kelsey
• Leslie K Ballas
• Sarah A Milgrom
• Ranjana Advani
• Margaret T Kasner
• Stella Flampouri
• Stephanie A Terezakis
• Mark Sellmyer
• John P Plastaras
• Bradford S Hoppe

Publication/Presentation Date

7-1-2025

Abstract

There has been a notable decrease in the use of radiation in lymphoma clinical practice and research in recent years. The NRG Hematologic Malignancies Working Group aimed to assess the inclusion of radiation oncology alongside haematology and oncology, pathology and molecular biology, and diagnostic radiology and nuclear medicine in lymphoma academic leadership positions. The haematology and oncology specialty had the highest representation among National Comprehensive Cancer Network lymphoma guideline committees, lymphoma research cooperative groups, lymphoma research foundations, and the editorial boards of seven high-impact haematology journals, with under-representation of radiation oncology and other specialties, such as diagnostic radiology and nuclear medicine. The NRG Hematologic Malignancies Working Group advocates for increased multidisciplinary representation and collaboration to enhance the quality of care and improve outcomes for patients with lymphoma.

Volume

12

Issue

7

First Page

555

Last Page

555

ISSN

2352-3026

Published In/Presented At

Saifi, O., Pinnix, C. C., Kelsey, C. R., Ballas, L. K., Milgrom, S. A., Advani, R., Kasner, M. T., Flampouri, S., Terezakis, S. A., Sellmyer, M., Plastaras, J. P., & Hoppe, B. S. (2025). Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups. The Lancet. Haematology, 12(7), e555–e559. https://doi.org/10.1016/S2352-3026(25)00080-8

Disciplines

Medicine and Health Sciences

PubMedID

40388957

Department(s)

Hematology-Medical Oncology Division

Document Type

Article